Figure 2.Differences in CENPU expression between breast cancer patients with different clinicopathological features. The clinicopathological features analyzed included (A) age, (B) SBR grade, (C) NPI score, (D) nodal status, (E) ER status, (F) PR status, (G) HER2 status, (H) HU's subtype, (I) RSSPC subtype, (J) basal-like status, (K) triple-negative status, (L) triple-negative and basal-like status.
